A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients

Dipeptidyl peptidase-4 (DPP-4) inhibitors could have antiatherosclerotic action, in addition to antihyperglycemic roles. Because macrophage foam cells are key components of atherosclerosis, we investigated the effect of the DPP-4 inhibitor teneligliptin on foam cell formation and its related gene ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Terasaki, Michishige, Hiromura, Munenori, Mori, Yusaku, Kohashi, Kyoko, Kushima, Hideki, Koshibu, Masakazu, Saito, Tomomi, Yashima, Hironori, Watanabe, Takuya, Hirano, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304851/
https://www.ncbi.nlm.nih.gov/pubmed/30627161
http://dx.doi.org/10.1155/2018/8458304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304851/
https://www.ncbi.nlm.nih.gov/pubmed/30627161
http://dx.doi.org/10.1155/2018/8458304

Ejemplares similares